[HTML] frontiersin.org

[HTML][HTML] Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - frontiersin.org
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …
被引用次数：16 相关文章
[HTML] nih.gov

[HTML][HTML] Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - epub.ub.uni-muenchen.de
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - europepmc.org
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - europepmc.org
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …